Infinity Pharmaceuticals, Inc.
INFI
INFI was delisted on the 13th of September, 2023.
97 hedge funds and large institutions have $82.5M invested in Infinity Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 19 closing their positions.
339% more call options, than puts
Call options by funds: $2.88M | Put options by funds: $655K
6% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 32
9% less funds holding
Funds holding: 107 → 97 (-10)
46% less capital invested
Capital invested by funds: $152M → $82.5M (-$69.5M)
53% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$6.28M |
| 2 |
GC
Gratus Capital
Atlanta,
Georgia
|
+$2.4M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.93M |
| 4 |
BlackRock
New York
|
+$1.72M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.54M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$5.1M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$4.35M |
| 4 |
GPC
Guardian Point Capital
Charlottesville,
Virginia
|
-$4.1M |
| 5 |
Two Sigma Investments
New York
|
-$2.43M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
AQR Capital Management
Greenwich,
Connecticut
| – | -$161K | -47,006 | Closed |
|
|
BAM
102
Belpointe Asset Management
Reno,
Nevada
| – | -$154K | -45,150 | Closed |
|
|
MIM
103
MetLife Investment Management
Whippany,
New Jersey
| – | -$113K | -33,123 | Closed |
|
|
MLICM
104
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$85.7K | -25,060 | Closed |
|
|
BAM
105
Blueshift Asset Management
Red Bank,
New Jersey
| – | -$74K | -21,609 | Closed |
|
|
BRWM
106
B. Riley Wealth Management
Memphis,
Tennessee
| – | -$65K | -19,000 | Closed |
|
|
TSS
107
Two Sigma Securities
New York
| – | -$39K | -11,428 | Closed |
|
|
IA
108
IFP Advisors
Tampa,
Florida
| – | -$27K | -8,000 | Closed |
|
|
GRP
109
Global Retirement Partners
San Rafael,
California
| – | -$3K | -800 | Closed |
|
|
OSAM
110
O'Shaughnessy Asset Management
Stamford,
Connecticut
| – | -$3K | -797 | Closed |
|
|
S
111
SignatureFD
Atlanta,
Georgia
| – | -$2K | -501 | Closed |
|
|
EI
112
Ellevest Inc
New York
| – | -$1K | -164 | Closed |
|
INFI Hedge Fund Activity: Q4 2021 in Review
97 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q4 2021, worth a combined $82.5M — down 46% from $152M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of INFI and 9 opened new positions — a net loss of 10 holders — while 32 trimmed existing stakes and 30 added.
The largest buyer was Polar Capital Holdings, adding an estimated $6.28M. The largest seller was Millennium Management, cutting an estimated $5.54M.
- 97 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q4 2021, down from 107 in Q3 2021.
- Funds reported $82.5M of Infinity Pharmaceuticals, Inc. stock for Q4 2021, down 46% quarter-over-quarter.
- 9 funds opened new Infinity Pharmaceuticals, Inc. positions in Q4 2021 and 19 closed out, a net change of -10 holders.
- The largest Infinity Pharmaceuticals, Inc. buyer in Q4 2021 was Polar Capital Holdings, an estimated $6.28M added.
- The largest Infinity Pharmaceuticals, Inc. seller in Q4 2021 was Millennium Management, an estimated $5.54M sold.
Based on aggregated 13F filings for Q4 2021.